![Page 1: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/1.jpg)
Special Web Call: Biofilms
PaulS.Anderson
©2016PSAnderson–www.ConsultDrAnderson.com
(c)PSAnderson-www.ConsultDrA.com-2016 1
![Page 2: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/2.jpg)
Conflict of interest:
• None
• IhavenofinancialconnectiontoANYlab,productorcompanymentioned
• SpecificproductsmentionedareexamplesofitemsIusecommonlyinpractice
2(c)PSAnderson-www.ConsultDrA.com-2016
![Page 3: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/3.jpg)
Next Regularly Scheduled Webcalls:
June BloodPressuremedications–PrescribingandTaperingtipsInthiswebcallDr.Andersonwilldescribetheclinicallyrelevantissuessurroundingthechoiceof,dosingforandtaperingoffofanti-hypertensivemedications.Howbesttodoit?Howtousenaturalmedicationsintheprocess?CaseexamplesandQ&Aincluded.CMETotal1.5hours–OfthatpharmacologyCMEis1.5hoursJuly Steroids–PrescribingandTaperingtipsInthiswebcallDr.Andersonwilldescribetheclinicallyrelevantissuessurroundingthechoiceof,dosingforandtaperingoffofsteroidmedications.Howbesttodoit?Howtousenaturalmedicationsintheprocess?CaseexamplesandQ&Aincluded.CMETotal1.5hours–OfthatpharmacologyCMEis1.5hours
(c)PSAnderson-www.ConsultDrA.com-2016 3
![Page 4: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/4.jpg)
Today's Topic Overview
BIOFILMS
• Discussionabouttheissuessurroundingbiofilmtherapies
• DiscussionofthesafeusesofbiofilmTxwithRx:
• Testing,dosingandfollowupwillbediscussed.
(c)PSAnderson-www.ConsultDrA.com-2016 4
![Page 5: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/5.jpg)
Biofilms
(c)PSAnderson-www.ConsultDrA.com-2016 5
![Page 6: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/6.jpg)
Summary
Biofilmsarebetterunderstoodthaneverbeforeastotheirmedical
relevanceinhumanillness.
Thisportionofthesessionisdesignedtopresentresearchedand
clinicallyverifiedtherapiesforbiofilmswhichcanbeappliedinchronic
diseasecare.
(c)PSAnderson-www.ConsultDrA.com-2016 6
![Page 7: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/7.jpg)
Biofilm Summary by Stephen E. Fry, MD
Biofilmsareconsideredtheruleinnatureratherthantheexception.Ifyouhavechronicinfection,biofilmsmaybeanunderlyingcause.Many,ifnotmost,microorganismsformandpersistincohesivecommunitystructurestermedbiofilms.Thesecellssecreteagelatinousintracellularsubstanceconsistingofanextracellularpolysaccharide(sugar),DNA,andproteinmatrix.Biofilmsareoftenfoundattachedtolivingandinertstablesurfacesthathaveaconstantliquidflowthatbringsnutrientsandremoveswasteproductsfromthebiofilms.Biofilmsoftenarenotcomposedofasingleorganism,butcontaintwoormoreorganismsmakingsignificantcontributionstothebiologicalstability,characteristics,andbehavioroftheresultingbiofilm.
(c)PSAnderson-www.ConsultDrA.com-2016 7
![Page 8: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/8.jpg)
Biofilm Summary by Stephen E. Fry, MD
Organismsfoundwithinbiofilmshavedistinctgeneticexpressionandfunctionalbehaviorcomparedtoindividualorganismssubsistinginanindividualplanktonicstate.Theestablishmentandlifecycleofbiofilmsonsurfacestypicallyproceedthroughfourmainstages:1) InitialAttachment,2)IrreversibleAttachment,3)Various
MaturationPhases,4)ActiveDispersionorBlebbing/Fragmenting.Manymicroorganismsspendmostoftheirlifecycleinapersistentbiofilmstateswitchingtofreelivingorplanktonicphasesonlyduringbriefperiodswhenenvironmentalconditionsarefavorable.
(c)PSAnderson-www.ConsultDrA.com-2016 8
![Page 9: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/9.jpg)
Overview
• InthepastthreeyearsweundertookaprojecttomergetheolderandemergingsciencearoundBiofilmsinhumanillnesswithclinicalpractice.
• ThiswascompletedatAndersonMedicalSpecialtyAssociateswiththecooperationofourpatientswithchronicinfectiousillnesses.
• Theseslidessummarizetheconceptsandtheirsuccessfulimplementationinthispopulation.
(c)PSAnderson-www.ConsultDrA.com-2016 9
![Page 10: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/10.jpg)
Biofilm Overview
• “Biofilm”isgenerallyagroupofbioticorganismswhichhaveaprotectivematrixofmetallo-mineralandorganicmoleculecoating.Thiscomplexprotectstheorganismsfromanti-infectivetherapiesandcreatea“super-biotic”organismcolony.• Abiofilmcanformalmostanywherewherewaterispresent.
• Thehumangut• Thebloodstream• Teeth.(thestickycoatingonteethafternobrushingyourteethisBiofilm.)
• InmostcasesthebiofilmmatrixisabletoprotecttheorganismcolonyfromeventhehighestandstrongestdosesofAntibiotics.
(c)PSAnderson-www.ConsultDrA.com-2016 10
![Page 11: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/11.jpg)
Who has biofilms?
• Everyone–butnotallareclinicallysignificant.
• Thosewithpositivelabtitersthatwon’tclearwithstandardofcaretreatment
• Thosewhoclearoneinfectiononlytogetanotheroranothergroup
• ThosewithchronicGIinfectionsthatareunresponsivetotreatment
• Anychronicallyillperson
• Etc…(c)PSAnderson-www.ConsultDrA.com-2016 11
![Page 12: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/12.jpg)
Can we test for biofilms?
• Let’sdiscuss…
• FryLabs(Scottsdale,Arizona)canrunbiofilmassays.
(c)PSAnderson-www.ConsultDrA.com-2016 12
![Page 13: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/13.jpg)
Biofilm Agents – A Spectrum:
1.Prevention:A. Inhibit:QuorumSensing
I. Organismcellsignalingwithauto-inducerswhichdeterminesgeneexpression,virulence,resistance,andthedevelopmentofbiofilms.
B. Inhibit:InitialAttachmentofBiofilmColoniesC. Inhibit:OrganismEffluxPump/MultiDrugResistancePump
Inhibitors2.Activetherapies:
A. Bacteriostatic&‘cidalagentsB. Directbiofilmdisruptionagents
(c)PSAnderson-www.ConsultDrA.com-2016 13
![Page 14: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/14.jpg)
Oral Biofilm Rx: Results
Phase-1(attachment/earlybiofilm) Phase-2LaterBiofilm
• Ascomparedtopreventivephase-1agents?• Ascomparedtootherphase-2agents?BOTTOMLINE:YOUCANNOTTREATPHASE-2BIOFILMS(whichallyourchronicallyillfolkshave)WITHPHASE-1THERAPIES.
(c)PSAnderson-www.ConsultDrA.com-2016 14
![Page 15: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/15.jpg)
Biofilm Agents – A Spectrum: 1-Prevention
• Enzymes
• Aromatics
• Tannins
• Phenolics
• Xylitol,Stevia
• Blackcumin
• Etc…
(c)PSAnderson-www.ConsultDrA.com-2016 15
![Page 16: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/16.jpg)
Badet C, Furiga A, Thébaud N. Effect of xylitol on an in vitro model of oral biofilm. Oral Health Prev Dent. 2008;6(4):337-41. PMID: 19178100 AbstractTheaimofthepresentstudywastoexaminewhetherxylitol,atdifferentconcentrations,inhibitstheformationofanexperimentalmodeloforalbiofilm.Biofilmsofsixbacterialspecies(Streptococcusmutans,Streptococcussobrinus,Lactobacillusrhamnosus,Actinomycesviscosus,PorphyromonasgingivalisandFusobacteriumnucleatum)werepreparedonhydroxyapatite(HA)discsaccordingtotheZürichBiofilmModel.Xylitolwastestedattwoconcentrations,1%and3%.Attheendoftheirdesignatedincubationtimes,someHAdiscsweredestinedforconfocallaserscanningmicroscopy(CLSM)andtheotherswereharvestedusingasterilesurgicalinstrument.Aliquotsofharvestedbiofilmsweredilutedandplatedontospecificmedia.Aftera48-hanaerobicincubationat37degreesC,thecolony-formingunits(CFUs)werecounted.CLSMimagesshowedthatonlyasmallamountofisolatedbacteriawasobservedonthesurfaceofHAdiscs.Cultureofharvestedbiofilmsshowedaninhibitioninthegrowthofdifferentspeciesincludedinthebiofilms.Xylitolhasaclearinhibitoryeffectontheformationoftheexperimentalbiofilms.Thisstudyshowsthatxylitolisnotonlyefficientininhibitingtheacidproductionofcariogenicbacteria,butalsoinpreventingtheformationofamultispeciesbiofilm;itconfirmstherelevanceoftheuseofthispolyolforthepreventionoforaldiseasescausedbydentalplaque.
(c)PSAnderson-www.ConsultDrA.com-2016 16
![Page 17: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/17.jpg)
P. A. S. Theophilus, M. J. Victoria, K. M. Socarras, K. R. Filush, K. Gupta, D. F. Luecke, and E. Sapi. Effectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of
Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031. PMCID: PMC4681354
Inthisstudy,weevaluatedtheeffectivenessofwholeleafSteviaextractagainstB.burgdorferispirochetes,persisters,andbiofilmformsinvitro.Thesusceptibilityofthedifferentformswasevaluatedbyvariousquantitativetechniquesinadditiontodifferentmicroscopymethods.TheeffectivenessofSteviawascomparedtodoxycycline,cefoperazone,daptomycin,andtheircombinations.OurresultsdemonstratedthatSteviahadsignificanteffectineliminatingB.burgdorferispirochetesandpersisters.SubcultureexperimentswithSteviaandantibioticstreatedcellswereestablishedfor7and14daysyielding,noand10%viablecells,respectivelycomparedtotheabove-mentionedantibioticsandantibioticcombination.WhenSteviaandthethreeantibioticsweretestedagainstattachedbiofilms,SteviasignificantlyreducedB.burgdorferiforms.ResultsfromthisstudysuggestthatanaturalproductsuchasStevialeafextractcouldbeconsideredasaneffectiveagentagainstB.burgdorferi.
(c)PSAnderson-www.ConsultDrA.com-2016 17
![Page 18: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/18.jpg)
Fatemeh Forouzanfar, Bibi Sedigheh Fazly Bazzaz, and Hossein Hosseinzadeh. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on
antimicrobial effects. Iran J Basic Med Sci. 2014 Dec; 17(12): 929–938. PMCID: PMC4387228
AllfindingsdiscussedaboveindicatethatN.sativaseedshaveantimicrobialeffectsagainstdifferentpathogens,includingbacteria,viruses,schistosomaandfungus.Blackcuminseedintraditionalmedicineandinrecentyearsforthetreatmentofmicrobialdiseaseshasbeenusedwithoutanyreportedsideeffects.Therefore,thisplantcanprovideavaluableagentformicrobialdiseases.However,additionalstudiesarerequiredtoevaluateandexplorethespecificcellularandmolecularmechanismsoftheantimicrobialeffectsofN.sativa,aloneorincombinationwithotherdrugs.
(c)PSAnderson-www.ConsultDrA.com-2016 18
![Page 19: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/19.jpg)
Park SR, et al. Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway. Nat Commun. 2016. PMID
26880271
And–onthehorizon:Pathogenicmicroorganismsoftenhavetheabilitytoattachtoasurface,buildingacomplexmatrixwheretheycolonizetoformabiofilm.Thiscellularsuperstructurecandisplayincreasedresistancetoantibioticsandcauseserious,persistenthealthproblemsinhumans.Herewedescribeahigh-throughputinvitroscreentoidentifyinhibitorsofAcinetobacterbaumanniibiofilmsusingalibraryofnaturalproductextractsderivedfrommarinemicrobes.AnalysisofextractsderivedfromStreptomycesgandocaensisresultsinthediscoveryofthreepeptidicmetabolites(cahuitamycinsA-C),withcahuitamycinCbeingthemosteffectiveinhibitor(IC50=14.5 μM).BiosynthesisofcahuitamycinCproceedsviaaconvergentbiosyntheticpathway,withoneofthestepsapparentlybeingcatalysedbyanunlinkedgeneencodinga6-methylsalicylatesynthase.EffortstoassessstarterunitdiversificationthroughselectivemutasynthesisleadtoproductionofunnaturalanaloguescahuitamycinsDandEofincreasedpotency(IC50=8.4and10.5 μM).
(c)PSAnderson-www.ConsultDrA.com-2016 19
![Page 20: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/20.jpg)
Biofilm Agents – A Spectrum: 2- Active Therapy
• AntimicrobialTherapies
• Natural(includingBlackCumin)
• Synthetic
• DirectBiofilmDisruption
• Agentsthatactuallydisruptand“open”thebiofilm
(c)PSAnderson-www.ConsultDrA.com-2016 20
![Page 21: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/21.jpg)
Considerations in Active Biofilm Therapy:
• OralBismuth
• EDTA
• Silvernanoparticles
• Anti-infective:• H2O2/HDIVC/Ge/Zn/etc…etc…
• Anti-infectiveagentsPO/IV
• Thiols• [Mono-]ALA,NAC,Glutathione
• [Di-]DMSA,DMPS
• OralBismuth-ThiolComplex
• Neitherbismuthnorthiolalonebuta
newmolecule.
(c)PSAnderson-www.ConsultDrA.com-2016 21
![Page 22: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/22.jpg)
Biofilm Protocols and EDTA:
• AlthoughatopicofgreatlengthwedoemployCalcium-disodiumEDTAandNa2-EDTAasadditivetosomeImmuneandAntibioticIVformulasasanaugmentforpatientswhomayhaveBiofilmissues.
SelectedEDTA-BiofilmReferences:[PMID:22941091;PMID:18594291;PMID:17909983;PMID:22029913;PMID:22941091;http://dx.doi.org/10.1016/j.fm.2011.07.009]
(c)PSAnderson-www.ConsultDrA.com-2016 22
![Page 23: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/23.jpg)
Biofilm Protocols and EDTA:
• TheformulashouldmeetthecriteriaforadditionofEDTA,andshould
begiveninaccordancewithacceptedmonitoringandfollowupof
EDTAtherapies–BUT-theadditionistypicallymuchlowerofadose
ofCa-EDTAthanachelationprotocol.
• IFEDTAisusedsomemineralscannotbeadministeredonthesame
day:Fe,Zn,Cu.
(c)PSAnderson-www.ConsultDrA.com-2016 23
![Page 24: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/24.jpg)
Biofilm Protocols and EDTA:
Astothequestionof“CanIjustrunmynormalEDTAchelationprotocolthen
doanIVofotherAnti-infective/Immunetherapies?”
• Sure.Inmostcaseshoweverthefullchelationprotocolusedforheavy
metalsisnotneededtoachievetheseeffects.
• **SeetheIIVNTPcourse“EDTAChelationandHeavyMetalToxicologyfor
detailsonheavymetaltreatment.[www.ivnutritionaltherapy.com]
(c)PSAnderson-www.ConsultDrA.com-2016 24
![Page 25: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/25.jpg)
Silver and Biofilms
SilverHydrosol(i.e.23ppmsilverhydrosol)areallIuse.Idonotuse“colloidal”forms.• AsamatterofprotocoltheSilverHydrosolIVcannotbegivenonthesamedaywiththechelators.• SilvernanoparticlesimpedethebiofilmformationbyPseudomonasaeruginosaandStaphylococcusepidermidis.ColloidsSurfBBiointerfaces.2010Sep1;79(2):340-4.doi:10.1016/j.colsurfb.2010.04.014.Epub2010Apr22.PMID:20493674
• Martinez-GutierrezF,BoegliL,AgostinhoA,SánchezEM,BachH,RuizF,JamesG.Anti-biofilmactivityofsilvernanoparticlesagainstdifferentmicroorganisms.Biofouling.2013;29(6):651-60.doi:10.1080/08927014.2013.794225.Epub2013Jun4.PMID:23731460
• BjarnsholtT,Kirketerp-MøllerK,KristiansenS,PhippsR,NielsenAK,JensenPØ,HøibyN,GivskovM.SilveragainstPseudomonasaeruginosabiofilms.APMIS.2007Aug;115(8):921-8.PMID:17696948
(c)PSAnderson-www.ConsultDrA.com-2016 25
![Page 26: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/26.jpg)
Bismuth:
• Multiplereferencesexistastothesynergyofbismuthwithbiofilm
disruption.
• DONOTUSEIVBISMUTHATTHISTIME–STICKWITHORAL.
*NOTE-Thereisaphysicianwholosthislicensebykillingapatient
withIVBismuth–itisnotneededasanIVadditiveandisnotreadyto
beusedIV!
(c)PSAnderson-www.ConsultDrA.com-2016 26
![Page 27: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/27.jpg)
Thiols (Mono and Di)
Dithiols:
• DMPS(IVandOraluse)
• DMSA(Oraluse)
Monothiols:
• ALA(OralorIVuse)
• NAC(OralorIVuse)
• Glutathione(IVuse)• Manythiolreferences.Somearelistedaboveinthebismuthsection.
(c)PSAnderson-www.ConsultDrA.com-2016 27
https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0ahUKEwjqmLb3zs_LAhUEzWMKHQpuDSUQjB0IBg&url=https%3A%2F%2Fcommons.wikimedia.org%2Fwiki%2FFile%3ADMSA-(2S%2C3S)https://www.google.com/search?q=ala+structure&rlz=1C1CHFX_enUS659US659&espv=2&biw=1366&bih=667&source=lnms&tbm=isch&sa=X&ved=0ahUKEwiDt-vLz8_LAhVU32MKHWULCL8Q_AUIBigB#tbm=isch&q=alpha+lipoic+acid+structure&imgrc=xFmpm-rxDdyL7M%3A
![Page 28: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/28.jpg)
Biofilm Concepts:
• Stackanti-infectiveIV’s(H2O2,HDIVC,Ge,Zn,Antibioticsetcetc…)alongwiththeIVchelators(EDTAformsandathiolappropriatelyadministered).
• GiveoralBismuth-Thiolcomplex
• Maybegivendailyifdesiredbutnotatthesametimeasanyotherproductordrugthatissensitivetobinding.
• Manyclinicsusehighdoseenzymes,Aromatics,Xylitol…orally(betweenmeals)daybeforeandoftheIVaswell.Somedothemdaily.
(c)PSAnderson-www.ConsultDrA.com-2016 28
![Page 29: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/29.jpg)
Considerations in Biofilm Therapy: EDTA
• OralBismuth-Thiolcomplex• 1–3capsulesQDawayfromfood
• EDTA• Ca-NA2EDTAaddedtoHDIVCorABXIV200-300mg• NA2EDTAaddedtoHDIVCorABXIV50-100mg• **OralCaEDTAascompoundedcapsuleorLiposphericpreparationfromAllergyResearchGrouporQuicksilver:4capsulesor2teaspoons
• Silver• IVonseparateday• Ororal23ppmSilverHydrosol15mLQID
(c)PSAnderson-www.ConsultDrA.com-2016 29
![Page 30: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/30.jpg)
General Doses in Biofilm Therapy:
• Thiols
• DMSA:
• Orally300-500mgPOawayfromfoodBIDdaypriortoandoftheIV
anti-infectiveprotocol
• DMPS:
• 25-50mggiveninaseparatebagfollowingtheIVanti-infective
protocol
(c)PSAnderson-www.ConsultDrA.com-2016 30
![Page 31: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/31.jpg)
General Doses in Biofilm Therapy:
• Thiols• ALA:
• Orally300-500mgBIDdaybeforeandoftheIVanti-infectiveprotocol–OR-20-100mggiveninaseparatebagfollowingtheIVanti-infectiveprotocol
• NAC:• Orally500-1000mgBIDdaybeforeandoftheIVanti-infectiveprotocol–OR-250-500mggiveninaseparatebagfollowingtheIVanti-infectiveprotocol
• Glutathione:• Astolerated,pernormalIVrules.Doseof1-4grams.
(c)PSAnderson-www.ConsultDrA.com-2016 31
![Page 32: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/32.jpg)
Oral Biofilm Rx: Results
Phase-1(attachment/earlybiofilm) Phase-2LaterBiofilm
• Ascomparedtopreventivephase-1agents?• Ascomparedtootherphase-2agents?BOTTOMLINE:YOUCANNOTTREATPHASE-2BIOFILMS(whichallyourchronicallyillfolkshave)WITHPHASE-1THERAPIES.
(c)PSAnderson-www.ConsultDrA.com-2016 32
![Page 33: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/33.jpg)
Oral Biofilm Rx: FAQ
• Isn’tbismuthtoxic?
• Notinthisform.Thisisneitherbismuthnorthiol.Thereasonareactiveform
ofbismuthandthiol(s)aremixedistocreateaNEWmolecule.Thenew
moleculeiswhatdisruptsthebiofilm.
(c)PSAnderson-www.ConsultDrA.com-2016 33
![Page 34: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/34.jpg)
Oral Biofilm Rx: FAQ
• Won’titchelatemypatient?
• Sameanswer–no.TheDithiolisboundtothebismuthsothetoxicityof
bismuthandchelatingabilityofthethiolsarenegated.
(c)PSAnderson-www.ConsultDrA.com-2016 34
![Page 35: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/35.jpg)
Oral Biofilm Rx: FAQ
• Doestheinitiationofimmunesymptomsafterstartingtheagent
meanitisnotworking?
• No.Infactitmeansitisworking.Youmayneedmoreanti-infective,
endocrine,inflammatoryorothersupportasthesymptomsmeanthe
immunesystemmaybe“seeing”theIDagentsforthefirsttime(dueto
openingofthebiofilm).
(c)PSAnderson-www.ConsultDrA.com-2016 35
![Page 36: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/36.jpg)
Oral Biofilm – Bismuth-Thiol Complex
• Morethanthesumofitsparts
• Pharmacologyverydifferentfromindividualparts
(c)PSAnderson-www.ConsultDrA.com-2016 36
![Page 37: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/37.jpg)
Biofilm Rx: FAQ
• InallyourresearchandhumantrialisIVadministeredbiofilmtherapy
morelikelyto“stirup”oraggravateapatientorisoralbiofilmRx
morelikely?
• InalmosteverycasewehaveseenMUCHmoreaggravationinoralbiofilm
therapy.FarlesswithIVtherapies.
• ThisislikelyduetothefactthatbiofilmsarethoughttostartintheGItract.
(c)PSAnderson-www.ConsultDrA.com-2016 37
![Page 38: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/38.jpg)
Free Bismuth
Metallo-attractivePortionToxicmetal/ReactivePortion
(c)PSAnderson-www.ConsultDrA.com-2016 38
![Page 39: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/39.jpg)
Free Thiol
StablePortionChelatingPortion
(c)PSAnderson-www.ConsultDrA.com-2016 39
![Page 40: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/40.jpg)
Bismuth-Thiol Complex
Non-toxicandnonchelatingportionsareonthe“outside”andaimintothebiofilmmatrixviabismuthmoietyattraction–createa“wedgeeffect”.
(c)PSAnderson-www.ConsultDrA.com-2016 40
BUGS-BUGS
![Page 41: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/41.jpg)
Bismuth-Thiol Complex
Non-toxicandnonchelatingportionsareonthe“outside”andaimintothebiofilmmatrixviabismuthmoietyattraction–createa“wedgeeffect”.
(c)PSAnderson-www.ConsultDrA.com-2016 41
BUGS-BUGS
So-“suddenly”theimmunesystem“sees”theBUGS!Anti-infectivesubstancesandimmuneactivitybeginthefighttheydidn’tknowwasneededbefore.
![Page 42: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/42.jpg)
Oral Biofilm Rx:
• IhaveworkedwithImprimispharmacy(US)tomake“Biosolve-PA”capsulesbasedonthestrongestingredientsavailableinthestudiesmentioned.• Initialtestingonhumansshowsverygoodtolerance.
• Formula:• DMPS25mg/AlphaLipoicAcid100mg/BismuthSubnitrate200mgperCapsule• Ideallynosubstitutions• DMSA100mgcansubforDMPS• BismuthSubcitratecansubforSubnitrate(willmakeproductweaker)
(c)PSAnderson-www.ConsultDrA.com-2016 42
![Page 43: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/43.jpg)
Oral Biofilm Rx:
• “Biosolve-PA”[Imakenomoneyfromthemanufactureorsaleofthisagent]dosing:• Approximatesthemostpotent–mostresearchedbiofilmdrugs• Usesthemost(available)formsandcombinationsofmedicationchemistry
• DOSE:• 1capQDawayfromfood,3Xaweekforoneweekasatestdose• 1-4capsQDtoBIDawayfromfood3-5Xaweek• Extradoses(onthe“offdays”)arehelpfulindermatologicflaresduringtherapyfordermatologicand‘Herx’typereactions
• Onceanimmunologicreactionisreachedthedosemayneedtobedecreasedasneeded
(c)PSAnderson-www.ConsultDrA.com-2016 43
![Page 44: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/44.jpg)
Oral Biofilm Rx:
• Normaltrialisfor60–120daysduringotheranti-infectivetherapy• Maybeusedmuchlongerifclinicallyindicated
• Usualtrajectoryoftherapy:• First30-60daysmayhavenochange
• Eventually(whenthebiofilmRxbreaksthebiofilmopen)thepatientwilltypicallyexhibitsignsofanimmunereaction.Thiscanbeanycytokinebasedreaction.
• Thisisthetimewhenabalancemustbestruck:
(c)PSAnderson-www.ConsultDrA.com-2016 44
![Page 45: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/45.jpg)
Oral Biofilm Rx:
• Thebalanceisbetweenallowingtheimmunereactionandtheanti-infectivetherapiestoworkandnothavingthepatientbetoouncomfortable.
• Theissueisenoughsupportwithoutsuppressingtheimmunesystemsoitcanreactfully.
(c)PSAnderson-www.ConsultDrA.com-2016 45
![Page 46: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/46.jpg)
Biofilm Rx Support:
• This“balanceisgainedtypicallybyallowingthebiofilmRxtocontinueandmodulatinganti-infectiveRxalongwithenoughAdrenal(andoccasionallyThyroid)support.
• Ifthepatientisonnon-Rxadrenalsupporttheymayneed5-10Xthedoseforatime.
• Iftheyareonlowdosehydrocortisoneandadrenalsupporttheyoftenwillneedmorehydrocortisone(sometimes2-4Xforatime).
(c)PSAnderson-www.ConsultDrA.com-2016 46
![Page 47: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/47.jpg)
What is next?
Phase-1(attachment/earlybiofilm) Phase-2LaterBiofilm
• Afteryouhavebrokenthroughthebiofilmandtherapyisprogressing(whichmaytake3-12months)thenyoucanphaseinthe“phase-1”agentstocleanupthebiofilmsthataremostclinicallysignificant–AND–keepthemfromre-forming.
(c)PSAnderson-www.ConsultDrA.com-2016 47
![Page 48: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/48.jpg)
References
(c)PSAnderson-www.ConsultDrA.com-2016 48
![Page 49: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/49.jpg)
Selected Bismuth / Biofilm References:
• Domenico,P.,B.A.Cunha,andR.J.Salo,ThePotentialofBismuth-ThiolsforTreatmentandPreventionofInfection.InfectMed,2000.17(2):p.123-127.
• Domenico,P.,etal.,CombatingAntibioticResistancewithBismuth-Thiols.Res.Adv.inAntimicrob.Agents&Chemother.,2003.3:p.79-85.
• Domenico,P.,etal.,Enhancementofbismuthantibacterialactivitywithlipophilicthiolchelators.AntimicrobAgentsChemother,1997.41(8):p.1697-703.
• Wu,C.L.,etal.,Subinhibitorybismuth-thiolsreducevirulenceofPseudomonasaeruginosa.AmJRespirCellMolBiol,2002.26(6):p.731-8.
• Microbionunpublisheddata.
• Domenico,P.,etal.,SurfaceantigenexposurebybismuthdimercaprolsuppressionofKlebsiellapneumoniaecapsularpolysaccharide.InfectImmun,1999.67(2):p.664-9.
(c)PSAnderson-www.ConsultDrA.com-2016 49
![Page 50: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/50.jpg)
Selected Bismuth / Biofilm References:
• Huang,C.T.andP.S.Stewart,ReductionofpolysaccharideproductioninPseudomonasaeruginosabiofilmsbybismuthdimercaprol(BisBAL)treatment.JAntimicrobChemother,1999.44(5):p.601-5.
• Domenico,P.,etal.,Activitiesofbismuththiolsagainststaphylococciandstaphylococcalbiofilms.AntimicrobAgentsChemother,2001.45(5):p.1417-21.
• Zhang,H.,etal.,Inhibitionofbacterialadherenceonthesurfaceofstentsandbacterialgrowthinbilebybismuthdimercaprol.DigDisSci,2005.50(6):p.1046-51.
• Alipour,M.,etal.,AttenuationofPseudomonasaeruginosavirulencefactorsandbiofilmsbyco-encapsulationofbismuthethanedithiolwithtobramycininliposomes.JAntimicrobChemother,2010.65(4):p.684-93.
• Domenico,P.,etal.,BisEDTandRIPactinsynergytopreventgraftinfectionsbyresistantstaphylococci.Peptides,2004.25(12):p.2047-53.31MicrobionCorporationIChemistryforLifeTM
(c)PSAnderson-www.ConsultDrA.com-2016 50
![Page 51: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/51.jpg)
Selected Bismuth-thiol references:
• MaryamVarposhti,AhyaAbdiAli,ParisaMohammadi.SynergisticEffectsofBismuthThiolsandVariousAntibioticsAgainstPseudomonasaeruginosaBiofilm.JundishapurJMicrobiol.7(3):e9142.March2014.DOI:10.5812/jjm.9142• J.P.Folsom,B.Baker,P.S.Stewart.Invitroefficacyofbismuththiolsagainstbiofilmsformedbybacteriaisolatedfromhumanchronicwounds.JournalofAppliedMicrobiology111,989–996ª2011TheSocietyforAppliedMicrobiology• ActivitiesofBismuthThiolsagainstStaphylococciandStaphylococcalBiofilms.ANTIMICROBIALAGENTSANDCHEMOTHERAPY,May2001,p.1417–1421.0066-4804/01/$04.0010DOI:10.1128/AAC.45.5.1417–1421.2001.
(c)PSAnderson-www.ConsultDrA.com-2016 51
![Page 52: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/52.jpg)
Background Biofilm References • Bryers,J.D.,Medicalbiofilms.BiotechnolBioeng,2008.100(1):p.1-18.• Gilbert,P.,P.J.Collier,andM.R.Brown,Influenceofgrowthrateonsusceptibilitytoantimicrobialagents:biofilms,cellcycle,dormancy,andstringentresponse.AntimicrobAgentsChemother,1990.34(10):p.1865-8.
• Zimmerli,W.,etal.,Pathogenesisofforeignbodyinfection:descriptionandcharacteristicsofananimalmodel.JInfectDis,1982.146(4):p.487-97.
• Murdoch,D.R.,etal.,InfectionoforthopedicprosthesesafterStaphylococcusaureusbacteremia.ClinInfectDis,2001.32(4):p.647-9.
• Costerton,J.W.,L.Montanaro,andC.R.Arciola,Biofilminimplantinfections:itsproductionandregulation.IntJArtifOrgans,2005.28(11):p.1062-8.
• Hostetler,S.G.,etal.,DischargePatternsofInjury-relatedHospitalizationswithanAcuteWoundintheUnitedStates.Wounds,2006.18(12):p.340-351.
• AmericanBurnAssociation.BurnincidenceandtreatmentintheUS:2000factsheet2000;Availablefrom:http://www.ameriburn.org.
• Vindenes,H.andR.Bjerknes,Microbialcolonizationoflargewounds.Burns,1995.21(8):p.575-579.
(c)PSAnderson-www.ConsultDrA.com-2016 52
![Page 53: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/53.jpg)
Biofilm Bibliography by Stephen E. Fry, MD 1.Costerton,J.W.,P.S.Stewart,andE.P.Greenberg,Bacterialbiofilms:acommoncauseofpersistentinfections.Science,1999.284(5418):p.131822.2.AlMutairi,D.andS.J.Kilty,Bacterialbiofilmsandthepathophysiologyofchronicrhinosinusitis.CurrOpinAllergyClinImmunol,2010.
3.Busscher,H.J.,etal.,Biofilmformationondentalrestorativeandimplantmaterials.JDentRes,2010.89(7):p.65765.
4.Cernohorska,L.andP.Slavikova,[AntibioticresistanceandbiofilmformationinPseudomonasaeruginosastrainsisolatedfrompatientswithurinarytractinfections].EpidemiolMikrobiolImunol,2010.59(4):p.1547.
5.Crawford,R.W.,etal.,GallstonesplayasignificantroleinSalmonellaspp.gallbladdercolonizationandcarriage.ProcNatlAcadSciUSA,2010.107(9):p.43538.
6.Cushion,M.T.,M.S.Collins,andM.J.Linke,BiofilmformationbyPneumocystisspp.EukaryotCell,2009.8(2):p.197206.
7.HallStoodley,L.andP.Stoodley,Evolvingconceptsinbiofilminfections.CellMicrobiol,2009.11(7):p.103443.
8.Haussler,S.andM.R.Parsek,Biofilms2009:newperspectivesattheheartofsurfaceassociatedmicrobialcommunities.JBacteriol,2010.192(12):p.29419.
9.Hoa,M.,etal.,Biofilmsandchronicotitismedia:aninitialexplorationintotheroleofbiofilmsinthepathogenesisofchronicotitismedia.AmJOtolaryngol,2010.31(4):p.2415.10.Jarvensivu,A.,etal.,Candidayeastsinchronicperiodontitistissuesandsubgingivalmicrobialbiofilmsinvivo.OralDis,2004.10(2):p.10612.
11.Klotz,S.A.,Fungaladherencetothevascularcompartment:acriticalstepinthepathogenesisofdisseminatedcandidiasis.ClinInfectDis,1992.14(1):p.3407.
(c)PSAnderson-www.ConsultDrA.com-2016 53
![Page 54: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/54.jpg)
Biofilm Bibliography by Stephen E. Fry, MD 12.Miller,V.M.,etal.,Evidenceofnanobacteriallikestructuresincalcifiedhumanarteriesandcardiacvalves.AmJPhysiolHeartCircPhysiol,2004.287(3):p.H111524.13.Tang,H.andY.Xu,[Bacterialbiofilmsandchronicosteomyelitis].ZhongguoXiuFuChongJianWaiKeZaZhi,2010.24(1):p.10811.14.Tapiainen,T.,etal.,BiofilmformationbyStreptococcuspneumoniaeisolatesfrompaediatricpatients.Apmis,2010.118(4):p.25560.15.Tunpiboonsak,S.,etal.,RoleofaBurkholderiapseudomalleipolyphosphatekinaseinanoxidativestressresponse,motilities,andbiofilmformation.JMicrobiol,2010.48(1):p.6370.16.Aulik,N.A.,etal.,Mannheimiahaemolyticaanditsleukotoxincauseneutrophilextracellulartrapformationbybovineneutrophils.InfectImmun,2010.78(11):p.445466.17.Behrendt,J.H.,etal.,NeutrophilextracellulartrapformationasinnateimmunereactionsagainsttheapicomplexanparasiteEimeriabovis.VetImmunolImmunopathol,2010.133(1):p.18.18.Dolgushin,IIandS.AndreevaIu,[Neutrophilextracellulartraps:methodofdetectionandassessmentofbacterialtrappingefficacy].ZhMikrobiolEpidemiolImmunobiol,2009(2):p.657.19.Ermert,D.,A.Zychlinsky,andC.Urban,Fungalandbacterialkillingbyneutrophils.MethodsMolBiol,2009.470:p.293312.20.Gupta,A.K.,etal.,NeutrophilNETs:anovelcontributortopreeclampsiaassociatedplacentalhypoxia?SeminImmunopathol,2007.29(2):p.1637.21.Gupta,A.K.,etal.,ActivatedendothelialcellsinduceneutrophilextracellulartrapsandaresusceptibletoNETosismediatedcelldeath.FEBSLett,2010.584(14):p.31937.
(c)PSAnderson-www.ConsultDrA.com-2016 54
![Page 55: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/55.jpg)
Biofilm Bibliography by Stephen E. Fry, MD 22.Hakkim,A.,etal.,ActivationoftheRafMEKERKpathwayisrequiredforneutrophilextracellulartrapformation.NatChemBiol,2010.23.Hakkim,A.,etal.,Impairmentofneutrophilextracellulartrapdegradationisassociatedwithlupusnephritis.ProcNatlAcadSciUSA,2010.107(21):p.98138.
24.Jann,N.J.,etal.,NeutrophilantimicrobialdefenseagainstStaphylococcusaureusismediatedbyphagolysosomalbutnotextracellulartrapassociatedcathelicidin.JLeukocBiol,2009.86(5):p.115969.
25.Li,P.,etal.,PAD4isessentialforantibacterialinnateimmunitymediatedbyneutrophilextracellulartraps.JExpMed,2010.207(9):p.185362.
26.Marcos,V.,etal.,CXCR2mediatesNADPHoxidaseindependentneutrophilextracellulartrapformationincysticfibrosisairwayinflammation.NatMed,2010.16(9):p.101823.
27.Pilsczek,F.H.,etal.,AnovelmechanismofrapidnuclearneutrophilextracellulartrapformationinresponsetoStaphylococcusaureus.JImmunol,2010.185(12):p.741325.
28.Urban,C.F.,etal.,NeutrophilextracellulartrapscaptureandkillCandidaalbicansyeastandhyphalforms.CellMicrobiol,2006.8(4):p.66876.
29.vonKockritzBlickwede,M.,etal.,Phagocytosisindependentantimicrobialactivityofmastcellsbymeansofextracellulartrapformation.Blood,2008.111(6):p.307080.
30.Wang,Y.,etal.,Histonehypercitrullinationmediateschromatindecondensationandneutrophilextracellulartrapformation.JCellBiol,2009.184(2):p.20513.
31.Wartha,F.,etal.,Neutrophilextracellulartraps:castingtheNEToverpathogenesis.CurrOpinMicrobiol,2007.10(1):p.526.
32.Wartha,F.andB.HenriquesNormark,ETosis:anovelcelldeathpathway.SciSignal,2008.1(21):p.pe25.
33.Ellis,J.E.,M.Prochazka,andS.E.Fry,EvidenceforInVivoHematologicBiofilmCommunitiesin3PatientswithALS.5thASMConf.onBiofilms,2009.158.
(c)PSAnderson-www.ConsultDrA.com-2016 55
![Page 56: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/56.jpg)
General Information - WebCalls
• EverythirdTuesdayofthemonth(Regularwebcalls)
• Pacifictime:5:30–7:00orwheneverwefinish
• Callswillberecordedandavailabletosubscribersanytimeafter
processing(usuallythedayfollowing).
• PowerPointfileswillbeavailableaftertodayspresentation
56(c)PSAnderson-www.ConsultDrA.com-2016
![Page 57: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/57.jpg)
General Information – “Subscriber Area”
• COMINGSOON:
• CMEwebinarseriesonchronicillness
• ClinicalChronicDiseaseandOncologyFellowship
• MonthlyWebCalls
• Eitherlevelofsubscriptionor“alacarte”
• Q&ABlog• Includedinpro-access
• Library• Includedinpro-access
57(c)PSAnderson-www.ConsultDrA.com-2016
![Page 58: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/58.jpg)
Past Webcall Topics Available:
1. EBVdiagnosisandTreatment2. Histamine–CNS3. Cortisol4. Iodine&T35. Biofilms(#1)6. DesiccatedThyroid7. Autoimmunity8. Histamine-Peripheral
9. Mitochondria10. ReDoxandInflammation11. IVandInjectionQ&A12. SulfationPathways13. AntidepressantRxandTaper14. PediatricRxanddose
adjustment15. RenalRxandDose
adjustments
(c)PSAnderson-www.ConsultDrA.com-2016 58
![Page 59: Special Web Call: Biofilms...May 31, 2016 · Borrelia Burgdorferi in Vitro. Eur J Microbiol Immunol (Bp). 2015 Dec; 5(4): 268–280. Published online 2015 Nov 12. doi: 10.1556/1886.2015.00031](https://reader035.vdocuments.us/reader035/viewer/2022071503/61232f468bed5245f15d7156/html5/thumbnails/59.jpg)
CME Certificate
Thisistoattestthat:Dr._________________________
Attendedthewebinar“SafeUsesofBiofilmTherapies”givenonlineliveorviarecordingonorafter05-31-2016.
Duration:1.5clockhoursPharmacology1.0hours
Thiseventdiscusseddiagnosis,treatmentandmanagementofbiofilmsandtherapiesassociatedwiththem.
Faculty:PaulS.Anderson,ND
59(c)PSAnderson-www.ConsultDrA.com-2016